Today’s clinical trials demand more than operational excellence — they require smarter designs, stronger collaboration and the ability to execute increasingly complex studies at scale. Fortrea is helping sponsors navigate this evolving landscape by delivering complex phase III clinical trials at scale while leveraging innovative technologies, adaptive methodologies, and deep therapeutic expertise to accelerate development and improve patient outcomes. This new Industry Pulse highlights how advances in clinical trial execution are reshaping drug development, from AI-driven protocol optimization and Bayesian statistical approaches to real-time data oversight and collaborative site engagement. Discover how organizations can reduce operational complexity, improve recruitment, strengthen data quality and bring innovative therapies to patients more efficiently. Inside, you’ll learn how: Fortrea delivers complex phase III clinical trials at scale AI is enhancing protocol design and trial efficiency Bayesian methods enable more adaptive clinical trials Real-time data is helping shape the future of regulatory oversight To utilize strategies for improving collaboration, recruitment and study execution
